Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer rated 'Overweight' on late stage pipeline
Pfizer rated 'Overweight' on late stage pipeline
Pfizer rated 'Overweight' on late stage pipeline
Submitted by
admin
on September 10, 2009 - 3:21pm
Source:
Yahoo/AP
News Tags:
Pfizer
pipelines
Wyeth
bapineuzumab
Sutent
Prevnar 13
Headline:
Pfizer rated 'Overweight' on late stage pipeline
Do Not Allow Advertisers to Use My Personal information
